Evolution of Active Surveillance - AlteraAI in Low Risk Prostate Cancer
Evolution of Active Surveillance - YouTube ASPI - Evolution of Active Surveillance Aug 26, 2024 Introduction “Evolution of Active Surveillance" features LeonardMarks, MD, professor of urology at David Geffen School of Medicine at UCLA , whose database of 5,000 patients was used to develop Avenda Health’s Unfold AIsystem . Marks said the system may be able to predict the durability of active surveillance using an AI map of prostate cancer to determine how big a lesion is. Marks says, “smaller is better” in terms of lesion size and durability of Active Surveillance as a management technique. Also featured is Scientific Director, Meghan Tierney from Artera , the developer of cancer diagnostics. Meghan is a Scientific Director with Artera. She is an RN and holds a PhD in nursing from the University of Minnesota. Her background spans oncology clinical practice and clinical research with a focus on improving outcomes and care experience for patients with cancer and their care pa